Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-969-9 | CAS number: 5188-07-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The LD50 of sodium methylmercaptide administered by oral route in the male rat was 116 (75-161) or 109 (84-146) mg/kg using the pure test substance. The test substance toxicity in the females was similar to that of the males.
The LD0 of sodium methylmercaptide when administered by dermal route in rats was > 400 mg/kg using the formulated test substance (21.2% in water).
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 116 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- discriminating dose
- Value:
- 85 mg/kg bw
Additional information
Oral route:
In a study conducted according to OECD Test Guideline 401 (Clouzeau, 1989), 5 male Sprague-Dawley rats/dose were given sodium methanethiolate via oral gavage (supplied as a 19.9% solution in water; diluted further in water and dosed at 10 ml/kg except for the high dose (which was administered at 2.05 ml/kg of the 19.9% solution); the doses were equivalent to 400, 620, 950, 1400 and 2000 mg/kg bw of the 19.9% solution or 80, 123, 189, 279, and 398 mg active ingredient (a.i.)/kg bw. Five female rats/group were dosed at 620, 950 and 2000 mg/kg bw (equivalent to 123, 189 and 398 mg a.i./kg bw). Animals were observed for 14 days after dosing. Mortality in the males was 1/5 and 2/5 at 400 and 620 mg/kg bw, respectively, and 5/5 at higher doses. Mortality was recorded within minutes of dosing. The mortality in the females was 3/5, 5/5, and 4/5 at 620, 950, and 2000 mg/kg bw, respectively. In males, a significant decrease in spontaneous activity and dyspnea at 400 and 620 mg/kg bw, tonic-clonic convulsions at the dose levels of 950 and 1400 mg/kg bw before death of the rats, and ataxia and coma at 2000 mg/kg bw were the main clinical signs recorded. Also in males, abnormal red coloration of the stomach was observed during the macroscopic examination of all animals from all dose levels found dead during the study. The necropsy performed on animals sacrificed at the end of the study revealed no macroscopic abnormalities. The toxicity in the females was similar to that of the males. The LD50 of the formulation (19.9% sodium methanethiolate solution) was 581 mg/kg bw, equivalent to 116 mg a.i./kg bw.
Dermal route
Sodium methanethiolate (21.2% solution in water) was applied directly to the skin of one male and one female rat at 2000 mg/kg body weight (424 mg active ingredient (a.i.) /kg bw) in an OECD TG 402 study (Clouzeau, 1994). After occlusion for 24 hours, tissue lesions on the whole depth of the skin were noted and these animals were euthanized for humane reasons. Eight additional rats (4/sex) were dosed with 400 mg/kg bw test solution in water (84.8 mg a.i. /kg bw). The dose site was wrapped with a semi-occlusive dressing for 24 hours. Two females exhibited reversible body weight loss and clinical signs that included hypoactivity and tremors between days 1 and 5. No cutaneous reactions or deaths were observed for any of the animals over the 14-day observation period, resulting in LD50of >400 mg/kg bw for the 21.2% water solution and > 84.8 mg/kg bw for the active ingredient.
Justification for classification or non-classification
According to REGULATION (EC) No 1272/2008:
Pure sodium methylmercaptide and water solutions [C >= 38%] should be classified as toxic if swallowed (category 3) and water solutions [C < 38%] should be classified as harmful if swallowed (category 4).
According to DIRECTIVE 67/548/EEC
Pure sodium methylmercaptide and water solutions [C >= 58%] should be classified as toxic if swallowed (T, R25) and water solutions [C < 58%] should be classified as harmful if swallowed (Xn, R22).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.